{
    "code": "02022048",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022048",
    "time": "2018-03-16 03:27:29",
    "許可證字號": "衛署藥輸字第022048號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/01\/19",
    "發證日期": "87\/01\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202204804",
    "中文品名": "剋癌易注射劑",
    "英文品名": "TAXOTERE CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION",
    "適應症": "乳癌、非小細胞肺癌、前列腺癌、胃腺癌、頭頸癌。",
    "劑型": "270注射劑",
    "包裝": "20MG\/80MG小瓶 100支以下盒裝 各附等支數0.5ML\/2ML小瓶附溶液",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "DOCETAXEL"
    ],
    "限制項目": "02輸　入 1Q不得輸入",
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F130069000  AVENTIS PHARMA (DAGENHAM)",
        "製造廠廠址": "DAGEHAM,ESSEX RM10 7XS,ENGLAND",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000200",
            "成分名稱": "DOCETAXEL",
            "含量描述": "",
            "含量": "40.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛署藥輸字第022048_Taxotere 2 vial_leaflet_E_CCDS v28_approved-102-09-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022048&Seq=108&Type=9"
        },
        {
            "title": "020220480008.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022048&Seq=008&Type=8"
        }
    ]
}